Pfizer’s respiratory syncytial virus (RSV) vaccine Abrysvo has shown efficacy in immunocompromised adults, the pharma announced Monday. In substudy B of Pfizer’s ongoing Phase 3 MONeT trial, Abrysvo ...

The Pfizer-Starboard Value plot has thickened considerably since news broke days ago that the activist investor took a $1 billion stake in the drugmaker. Shortly after former Pfizer CEO Ian Read and ...

Pfizer signaled Tuesday it expects a challenging 2026 as it invests in new products to offset declines in Covid-19 revenues ...

Pfizer Inc forecast little to no sales growth next year as the drugmaker undertakes an effort to refresh its pipeline of hit ...

Pfizer has added another chapter to its long-running drug discovery collaboration with Chinese tech startup XtalPi, this time upgrading their molecular modeling work. The aim is to help “grasp ...

Co announces it has entered into a worldwide collaboration and licensing agreement with Pfizer for the discovery, development and commercialization of compounds which modulate three specific sodium ...

Pfizer and BioNTech announced Thursday that they have begun a study to test a combination vaccine for COVID-19 and the flu. In a news release, the drugmakers said they started a Phase 1 trial of an ...

Cipla Ltd has inked an exclusive agreement with Pfizer India to market, distribute, and sell the latter's four brands across ...